65 GROVE STREET, WATERTOWN, MA
2026 Annual Meeting Results - Election of Three Class I Directors
Announces Strategic Licensing Agreement to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases
Investor Presentation
Reports First Quarter 2026 Financial Results and Provides Business Update
Financial Results, Press Release
Announces the Appointment of Adrian Bot to Board of Directors
Reg. FD, Other Events
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Schedule 13G - Ownership Report
Post-Effective Amendment to Registration Statement
Prospectus filed pursuant to Rule 424(b)(7)
Correspondence